Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells - PubMed (original) (raw)
Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells
V Vetvicka et al. J Clin Invest. 1996.
Abstract
When phagocyte CR3 binds to iC3b on bacteria or yeast, phagocytosis and degranulation are triggered because of simultaneous recognition of iC3b via a CD11b I-domain binding site and specific microbial polysaccharides via a lectin site located COOH-terminal to the I-domain. By contrast, when phagocyte or natural killer (NK) cell CR3 adheres to iC3b on erythrocytes or tumor cells that lack CR3-binding membrane polysaccharides, neither lysis nor cytotoxicity are stimulated. This investigation showed that soluble CR3-specific polysaccharides such as beta-glucan induced a primed state of CR3 that could trigger killing of iC3b-target cells that were otherwise resistant to cytotoxicity. Anti-CR3 added before sugars prevented priming, whereas anti-CR3 added after sugars blocked primed CR3 attachment to iC3b-targets. Polysaccharide priming required tyrosine kinase(s) and a magnesium-dependent conformational change of the I-domain that exposed the CBRM1/5 activation epitope. Unlike LPS or cytokines, polysaccharides did not up-regulate neutrophil CR3 expression nor expose the mAb 24 reporter epitope representing the high affinity ICAM-1-binding state. The current data apparently explain the mechanism of tumoricidal beta-glucans used for immunotherapy. These polysaccharides function through binding to phagocyte or NK cell CR3, priming the receptor for cytotoxicity of neoplastic tissues that are frequently targeted with iC3b and sparing normal tissues that lack iC3b.
Comment in
- The continuing saga of complement receptor type 3 (CR3).
Todd RF 3rd. Todd RF 3rd. J Clin Invest. 1996 Jul 1;98(1):1-2. doi: 10.1172/JCI118752. J Clin Invest. 1996. PMID: 8690779 Free PMC article. No abstract available.
Similar articles
- Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.
Vĕtvicka V, Hanikýrová M, Vĕtvicková J, Ross GD. Vĕtvicka V, et al. Clin Exp Immunol. 1999 Feb;115(2):229-35. doi: 10.1046/j.1365-2249.1999.00800.x. Clin Exp Immunol. 1999. PMID: 9933447 Free PMC article. - CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.
Ross GD, Vĕtvicka V. Ross GD, et al. Clin Exp Immunol. 1993 May;92(2):181-4. doi: 10.1111/j.1365-2249.1993.tb03377.x. Clin Exp Immunol. 1993. PMID: 8485905 Free PMC article. Review.
Cited by
- Complement receptor 3-dependent engagement by Candida glabrata β-glucan modulates dendritic cells to induce regulatory T-cell expansion.
Kunanopparat A, Dinh TTH, Ponpakdee P, Padungros P, Kaewduangduen W, Ariya-Anandech K, Tummamunkong P, Samaeng A, Sae-Ear P, Leelahavanichkul A, Hirankarn N, Ritprajak P. Kunanopparat A, et al. Open Biol. 2024 May;14(5):230315. doi: 10.1098/rsob.230315. Epub 2024 May 29. Open Biol. 2024. PMID: 38806144 Free PMC article. - Hyphal Als proteins act as CR3 ligands to promote immune responses against Candida albicans.
Zhou T, Solis NV, Marshall M, Yao Q, Garleb R, Yang M, Pearlman E, Filler SG, Liu H. Zhou T, et al. Nat Commun. 2024 May 9;15(1):3926. doi: 10.1038/s41467-024-48093-8. Nat Commun. 2024. PMID: 38724513 Free PMC article. - Screening and Characteristics Analysis of Polysaccharides from Orah Mandarin (Citrus reticulata cv. Orah).
Liu G, Wei P, Tang Y, Li J, Yi P, Deng Z, He X, Ling D, Sun J, Zhang L. Liu G, et al. Foods. 2023 Dec 25;13(1):82. doi: 10.3390/foods13010082. Foods. 2023. PMID: 38201110 Free PMC article. - Receptor basis of biological activity of polysaccharides.
Generalov E, Yakovenko L. Generalov E, et al. Biophys Rev. 2023 Jul 27;15(5):1209-1222. doi: 10.1007/s12551-023-01102-4. eCollection 2023 Oct. Biophys Rev. 2023. PMID: 37975017 Free PMC article. Review. - Mucosal Infection with Unmasked Candida albicans Cells Impacts Disease Progression in a Host Niche-Specific Manner.
Wagner AS, Vogel AK, Lumsdaine SW, Phillips EK, Willems HME, Peters BM, Reynolds TB. Wagner AS, et al. Infect Immun. 2022 Dec 15;90(12):e0034222. doi: 10.1128/iai.00342-22. Epub 2022 Nov 14. Infect Immun. 2022. PMID: 36374100 Free PMC article.
References
- Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1270-6 - PubMed
- Eur J Clin Pharmacol. 1992;42(6):623-7 - PubMed
- J Immunol. 1979 Aug;123(2):607-11 - PubMed
- J Immunol. 1992 Feb 15;148(4):1080-5 - PubMed
- EMBO J. 1989 Dec 1;8(12):3759-65 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials